4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-062613
Chief Medical Officer sold 6,250 shares at an average $50.41 ($315,088)
- Chief Medical Officer acquired 6,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
BALDO LANCE · Chief Medical Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-12-07 | Exercise or conversion : show line 1 in the form | +6,250 | $7.80 | $48,750 | 6,250 | D |
| 2020-12-07 | Sale : show line 2 in the form | −780 | $48.79 | $38,056 | 5,470 | D |
| 2020-12-07 | Sale : show line 3 in the form | −3,000 | $50.14 | $150,420 | 2,470 | D |
| 2020-12-07 | Sale : show line 4 in the form | −2,470 | $51.26 | $126,612 | 0 | D |
| Open-market sales · 6,250 sh · avg $50.41 · $315,088 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-12-07 | Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) | −6,250 | 381,250 | D |
Loading xslF345X03/doc4.xml…